Will Bausch + Lomb break free from debt-heavy Bausch Health? Sale rumours ignite market frenzy!
Bausch + Lomb saw its stock surge by 13% in Toronto, trading at 24.01 Canadian dollars (around $17.67), following a report by the Financial Times ... Read More
Valeant Pharmaceuticals to divest Sprout Pharmaceuticals in strategic move
Valeant Pharmaceuticals International has announced a significant transaction involving the sale of Sprout Pharmaceuticals back to its original owners. This strategic divestiture includes a deal ... Read More